Stocks
Chiron International PLC S (Ireland)ENPD
HealthcareBiotechnology
A specialty pharmaceutical company focused on developing and commercializing treatments for central nervous system disorders. Its lead product candidates target underserved patient populations, and investors track the stock for its clinical pipeline and regulatory milestones.
Congressional Interest in Chiron International PLC S (Ireland) (ENPD)
1 member of Congress has disclosed 1 trade in Chiron International PLC S (Ireland) (ENPD), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading ENPD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-03-17 | JAMES B. RENACCI | buy | $1K-$15K |